Last updated on August 2014

Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)


Brief description of study

Sustained Treatment of Paroxysmal Atrial Fibrillation Post-Approval Study (STOP AF PAS)

Detailed Study Description

To provide clinical data regarding the long-term safety and effectiveness of the Arctic Front® Cardiac Cryoablation Catheter System, including the Freezor® MAX Cardiac cryoablation catheter according to the Product Labeling.

Demonstrate effectiveness (through 36 months) by assessing the rate of subjects free of chronic treatment failure with paroxysmal atrial fibrillation who have failed one or more Atrial Fibrillation Drugs.

Clinical Study Identifier: TX138993

Contact Investigators or Research Sites near you

Start Over

Richard Vargas

Baylor Scott & White Research Institute
Dallas, TX USA
  Connect »